{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:31Z","timestamp":1792723171579,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM008638"],"award-info":[{"award-number":["T32 GM008638"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018232","name":"Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania","doi-asserted-by":"publisher","award":["Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania"],"award-info":[{"award-number":["Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania"]}],"id":[{"id":"10.13039\/100018232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medical advances in diagnosis and management have increased the life expectancy of many pediatric-onset rare diseases, including inherited metabolic disorders (IMDs). Historically fatal childhood conditions are now manageable chronic illnesses, with over 90% of individuals with IMD reaching adulthood. As more individuals with IMDs reach adulthood (age 18 years), there is a new imperative for health care transition planning that promotes developmentally-appropriate skills for medical self-management and independent living. Knowledge gaps on the long-term disease-related outcomes limit our ability to provide evidence-based resources for transition. Maple Syrup Urine Disease (MSUD) is an IMD with a global incidence of 1:185,000. It is increasingly diagnosed through population-level newborn screening, which allows for early treatment with dietary restrictions of branched chain amino acids and urgent intervention during episodes of catabolic stress. Due to the success of newborn screening programs, there is a growing population of adults with MSUD, making it a model for exploring the current state of transition and adult outcomes in IMDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We used a qualitative case-study approach to assess the lived experiences of adults with MSUD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) or caregivers to adults with MSUD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098). Analysis of their semi-structured interviews identified common themes including: (1) poor, non-standardized health care transition; (2) less emphasis on dietary management; (3) changing symptomatology with new presentations of fatigue, brain fog, and panic attacks; (3) emerging concerns related to adult health care, including comorbid adult-onset conditions, mental health, and lack of knowledgeable adult providers; (4) wide-ranging functional outcomes for education, employment, and financial independence; and (5) attainment of new milestones including romantic partnership and parenthood; and (6) greater concern about the supports needed to achieve independent living.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individuals with MSUD are reaching milestones of adulthood and have new priorities for their healthcare and lifestyle. Evidence-based healthcare transition is needed to support their transition to independent living.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04383-6","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:13:36Z","timestamp":1784967216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating adulthood with maple syrup urine disease: patient and caregiver perspectives on healthcare transition and independent living"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-4214","authenticated-orcid":false,"given":"Jessica I.","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Grabill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dolins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bat-Zion","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ganetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"4383_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/8904_2015_435","volume":"27","author":"S Sirrs","year":"2016","unstructured":"Sirrs S, Hollak C, Merkel M, et al. The Frequencies of Different Inborn Errors of Metabolism in Adult Metabolic Centres: Report from the SSIEM Adult Metabolic Physicians Group. JIMD Rep. 2016;27:85\u201391. https:\/\/doi.org\/10.1007\/8904_2015_435.","journal-title":"JIMD Rep"},{"issue":"1","key":"4383_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13023-020-01471-z","volume":"15","author":"K Gariani","year":"2020","unstructured":"Gariani K, Nascimento M, Superti-Furga A, Tran C. Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics. Orphanet J Rare Dis. 2020;15(1):210. https:\/\/doi.org\/10.1186\/s13023-020-01471-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl","key":"4383_CR3","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1542\/peds.2010-1466F","volume":"126","author":"DS Lotstein","year":"2010","unstructured":"Lotstein DS, Kuo AA, Strickland B, Tait F. The transition to adult health care for youth with special health care needs: do racial and ethnic disparities exist? Pediatrics. 2010;126(Suppl):S129\u201336. https:\/\/doi.org\/10.1542\/peds.2010-1466F.","journal-title":"Pediatrics"},{"issue":"3","key":"4383_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jamapediatrics.2015.3168","volume":"170","author":"C Fair","year":"2016","unstructured":"Fair C, Cuttance J, Sharma N, et al. International and Interdisciplinary Identification of Health Care Transition Outcomes. JAMA Pediatr. 2016;170(3):205\u201311. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.3168.","journal-title":"JAMA Pediatr"},{"key":"4383_CR5","doi-asserted-by":"publisher","unstructured":"Sandquist M, Davenport T, Monaco J, Lyon ME. The transition to adulthood for youth living with rare diseases. Children (Basel). 2022;9(5). https:\/\/doi.org\/10.3390\/children9050710.","DOI":"10.3390\/children9050710"},{"key":"4383_CR6","unstructured":"Gold Ji, Strong A, Gold NB, et al. The current state of adult metabolic medicine in the United States: results of a nationwide survey. Genet Med."},{"key":"4383_CR7","doi-asserted-by":"publisher","unstructured":"Gold JI, Stepien KM. Healthcare transition in inherited metabolic disorders-is a collaborative approach between US and European centers possible? J Clin Med. 2022;11(19). https:\/\/doi.org\/10.3390\/jcm11195805.","DOI":"10.3390\/jcm11195805"},{"key":"4383_CR8","unstructured":"Got Transition. Transitioning to an adult approach to care without changing clinicians."},{"key":"4383_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.genom.3.022502.103213","volume":"3","author":"DH Chace","year":"2002","unstructured":"Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet. 2002;3:17\u201345. https:\/\/doi.org\/10.1146\/annurev.genom.3.022502.103213.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"6","key":"4383_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ajmg.a.61124","volume":"179","author":"CR Ferreira","year":"2019","unstructured":"Ferreira CR. The burden of rare diseases. Am J Med Genet A. 2019;179(6):885\u201392. https:\/\/doi.org\/10.1002\/ajmg.a.61124.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"4383_CR11","doi-asserted-by":"publisher","first-page":"e70057","DOI":"10.1002\/jimd.70057","volume":"48","author":"M Langeveld","year":"2025","unstructured":"Langeveld M, Sirrs S, Schoenmakers DH, et al. Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases. J Inherit Metab Dis. 2025;48(4):e70057. https:\/\/doi.org\/10.1002\/jimd.70057.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"4383_CR12","first-page":"25","volume":"99","author":"P Kruszka","year":"2019","unstructured":"Kruszka P, Regier D. Inborn Errors of Metabolism: From Preconception to Adulthood. Am Fam Physician. 2019;99(1):25\u201332.","journal-title":"Am Fam Physician"},{"issue":"2","key":"4383_CR13","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.1002\/jimd.70005","volume":"48","author":"M Tchan","year":"2025","unstructured":"Tchan M, Lehman A, van Dussen L, et al. The Frequencies of Different Inborn Errors of Metabolism in Adult Metabolic Centres: 10 Years Later, Another Report From the SSIEM Adult Metabolic Physicians Group. J Inherit Metab Dis. 2025;48(2):e70005. https:\/\/doi.org\/10.1002\/jimd.70005.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"4383_CR14","doi-asserted-by":"publisher","first-page":"e12827","DOI":"10.1002\/jimd.12827","volume":"48","author":"JI Gold","year":"2025","unstructured":"Gold JI, Strong A, Gold NB, et al. Executive and adaptive function impacts long-term outcomes for adults with maple syrup urine disease. J Inherit Metab Dis. 2025;48(1):e12827. https:\/\/doi.org\/10.1002\/jimd.12827.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4383_CR15","first-page":"315","volume":"13","author":"GM Enns","year":"2002","unstructured":"Enns GM, Packman W. The adolescent with an inborn error of metabolism: medical issues and transition to adulthood. Adolesc Med. 2002;13(2):315\u201329. vii.","journal-title":"Adolesc Med"},{"issue":"1","key":"4383_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jimd.12709","volume":"47","author":"J Baruteau","year":"2024","unstructured":"Baruteau J, Brunetti-Pierri N, Gissen P. Liver-directed gene therapy for inherited metabolic diseases. J Inherit Metab Dis. 2024;47(1):9\u201321. https:\/\/doi.org\/10.1002\/jimd.12709.","journal-title":"J Inherit Metab Dis"},{"issue":"22","key":"4383_CR17","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","volume":"392","author":"K Musunuru","year":"2025","unstructured":"Musunuru K, Grandinette SA, Wang X, et al. Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease. N Engl J Med. 2025;392(22):2235\u201343. https:\/\/doi.org\/10.1056\/NEJMoa2504747.","journal-title":"N Engl J Med"},{"issue":"3","key":"4383_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jimd.12209","volume":"43","author":"MT Gerstein","year":"2020","unstructured":"Gerstein MT, Markus AR, Gianattasio KZ, et al. Choosing between medical management and liver transplant in urea cycle disorders: A conceptual framework for parental treatment decision-making in rare disease. J Inherit Metab Dis. 2020;43(3):438\u201358. https:\/\/doi.org\/10.1002\/jimd.12209.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"4383_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","volume":"129","author":"KA Strauss","year":"2020","unstructured":"Strauss KA, Carson VJ, Soltys K, et al. Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes. Mol Genet Metab. 2020;129(3):193\u2013206. https:\/\/doi.org\/10.1016\/j.ymgme.2020.01.006.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"4383_CR20","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI67217","volume":"123","author":"ER Muelly","year":"2013","unstructured":"Muelly ER, Moore GJ, Bunce SC, et al. Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest. 2013;123(4):1809\u201320. https:\/\/doi.org\/10.1172\/JCI67217.","journal-title":"J Clin Invest"},{"key":"4383_CR21","unstructured":"Conditions Added to the Recommended Universal Screening Panel. Accessed September 12. 2025. https:\/\/www.hrsa.gov\/advisory-committees\/heritable-disorders\/rusp\/previous-nominations."},{"key":"4383_CR22","doi-asserted-by":"publisher","unstructured":"Gold JI, Strong A, Gold NB, et al. Impact of executive and adaptive function on functional outcomes in adults with maple syrup urine disease. medRxiv. 2024;2024.05.17.24307509. https:\/\/doi.org\/10.1101\/2024.05.17.24307509.","DOI":"10.1101\/2024.05.17.24307509"},{"issue":"5","key":"4383_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s10897-012-9490-1","volume":"21","author":"W Packman","year":"2012","unstructured":"Packman W, Mehta I, Rafie S, Mehta J, Naldi M, Mooney KH. Young adults with MSUD and their transition to adulthood: psychosocial issues. J Genet Couns. 2012;21(5):692\u2013703. https:\/\/doi.org\/10.1007\/s10897-012-9490-1.","journal-title":"J Genet Couns"},{"key":"4383_CR24","unstructured":"Robson C, McCartan K. Real World Research. 4th ed. Wiley; 2016."},{"key":"4383_CR25","doi-asserted-by":"publisher","first-page":"100088","DOI":"10.1016\/j.hctj.2024.100088","volume":"3","author":"D San Martin-Feeney","year":"2025","unstructured":"San Martin-Feeney D, Samborn S, Allemang B, et al. Transition experiences of adolescents and young adults working with a patient navigator. Heal care transitions. 2025;3:100088. https:\/\/doi.org\/10.1016\/j.hctj.2024.100088.","journal-title":"Heal care transitions"},{"issue":"9","key":"4383_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/jpepsy\/jsx076","volume":"42","author":"JS Pierce","year":"2017","unstructured":"Pierce JS, Aroian K, Schifano E, et al. Health Care Transition for Young Adults With Type 1 Diabetes: Stakeholder Engagement for Defining Optimal Outcomes. J Pediatr Psychol. 2017;42(9):970\u201382. https:\/\/doi.org\/10.1093\/jpepsy\/jsx076.","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"4383_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyng\u00e4s H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107\u201315. https:\/\/doi.org\/10.1111\/j.1365-2648.2007.04569.x.","journal-title":"J Adv Nurs"},{"key":"4383_CR28","unstructured":"Patton M. Qualitative Research and Evaluation Methods. Sage; 2002."},{"issue":"1","key":"4383_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s41687-023-00635-2","volume":"7","author":"JA Randall","year":"2023","unstructured":"Randall JA, Sutter C, Raither L, et al. Understanding the patient experience of Classic Galactosemia in pediatric and adult patients: increased disease burden, challenges with daily living, and how they evolve over time. J patient-reported outcomes. 2023;7(1):95. https:\/\/doi.org\/10.1186\/s41687-023-00635-2.","journal-title":"J patient-reported outcomes"},{"key":"4383_CR30","doi-asserted-by":"publisher","first-page":"983154","DOI":"10.3389\/fpsyg.2022.983154","volume":"13","author":"M-E O\u2019Shea","year":"2022","unstructured":"O\u2019Shea M-E, Sheehan Gilroy B, Greaney A-M, MacDonald A. Moving through adulthood: The lived experience of Irish adults with PKU. Front Psychol. 2022;13:983154. https:\/\/doi.org\/10.3389\/fpsyg.2022.983154.","journal-title":"Front Psychol"},{"issue":"1262","key":"4383_CR31","first-page":"U2728","volume":"120","author":"N Frank","year":"2007","unstructured":"Frank N, Fitzgerald R, Legge M. Phenylketonuria\u2013the lived experience. N Z Med J. 2007;120(1262):U2728.","journal-title":"N Z Med J"},{"key":"4383_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pedn.2020.08.021","volume":"55","author":"M Varty","year":"2020","unstructured":"Varty M, Speller-Brown B, Phillips L, Kelly KP. Youths\u2019 Experiences of Transition from Pediatric to Adult Care: An Updated Qualitative Metasynthesis. J Pediatr Nurs. 2020;55:201\u201310. https:\/\/doi.org\/10.1016\/j.pedn.2020.08.021.","journal-title":"J Pediatr Nurs"},{"key":"4383_CR33","unstructured":"Graham-Rowe D. Ready, steady, go. New Scientist. 1999. Available from: https:\/\/www.nice.org.uk\/sharedlearning\/implementing-transition-care-locally-and-nationally-using-the-ready-steady-go-programme. Accessed 15 Apr 2022."},{"key":"4383_CR34","doi-asserted-by":"publisher","first-page":"652358","DOI":"10.3389\/fmed.2021.652358","volume":"8","author":"KM Stepien","year":"2021","unstructured":"Stepien KM, Kie\u0107-Wilk B, Lampe C, et al. Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey. Front Med. 2021;8:652358. https:\/\/doi.org\/10.3389\/fmed.2021.652358.","journal-title":"Front Med"},{"issue":"2","key":"4383_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S2213-8587(18)30369-3","volume":"7","author":"F Hannah-Shmouni","year":"2019","unstructured":"Hannah-Shmouni F, Stratakis CA, Sechi A, et al. Subspecialty training in adult inherited metabolic diseases: a call to action for unmet needs. lancet Diabetes Endocrinol. 2019;7(2):82\u20134. https:\/\/doi.org\/10.1016\/S2213-8587(18)30369-3.","journal-title":"lancet Diabetes Endocrinol"},{"issue":"5","key":"4383_CR36","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1542\/peds.2009-1814","volume":"125","author":"AJ Barnes","year":"2010","unstructured":"Barnes AJ, Eisenberg ME, Resnick MD. Suicide and self-injury among children and youth with chronic health conditions. Pediatrics. 2010;125(5):889\u201395. https:\/\/doi.org\/10.1542\/peds.2009-1814.","journal-title":"Pediatrics"},{"issue":"12","key":"4383_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/0706743717727242","volume":"62","author":"MA Ferro","year":"2017","unstructured":"Ferro MA, Rhodes AE, Kimber M, et al. Suicidal Behaviour Among Adolescents and Young Adults with Self-Reported Chronic Illness. Can J Psychiatry. 2017;62(12):845\u201353. https:\/\/doi.org\/10.1177\/0706743717727242.","journal-title":"Can J Psychiatry"},{"issue":"3","key":"4383_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamapediatrics.2023.5914","volume":"178","author":"KV Prussien","year":"2024","unstructured":"Prussien KV, Crosby LE, Faust HL, et al. An Updated Equitable Model of Readiness for Transition to Adult Care: Content Validation in Young People With Sickle Cell Disease. JAMA Pediatr. 2024;178(3):274\u201382. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.5914.","journal-title":"JAMA Pediatr"},{"issue":"10","key":"4383_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamapediatrics.2013.2223","volume":"167","author":"LA Schwartz","year":"2013","unstructured":"Schwartz LA, Brumley LD, Tuchman LK, et al. Stakeholder validation of a model of readiness for transition to adult care. JAMA Pediatr. 2013;167(10):939\u201346. https:\/\/doi.org\/10.1001\/jamapediatrics.2013.2223.","journal-title":"JAMA Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04383-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:19:53Z","timestamp":1792721993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04383-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4383"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04383-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8231788\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Children\u2019s Hospital of Philadelphia IRB (IRB#21-18443). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study. Proof that informed consent was obtained is available upon request.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"373"}}